颈动脉狭窄相关研究进展
Research Progress Related to Carotid Artery Stenosis
DOI: 10.12677/acm.2025.1551552, PDF,   
作者: 林 阳:绍兴文理学院医学院,浙江 绍兴;赵文军*:浙江省台州医院血管外科,浙江 台州
关键词: 颈动脉狭窄颈动脉斑块颈动脉血运重建颈动脉支架缺血性中风Carotid Artery Stenosis Carotid Artery Plaque Carotid Artery Revascularization Carotid Artery Stent Ischemic Stroke
摘要: 颈动脉狭窄使患者有缺血性中风的危险,因此临床治疗的目标往往是降低患者并发卒中的风险。大多数颈动脉狭窄患者往往在临床上表现为无症状。颈动脉狭窄引起的中风最常见的机制是斑块破裂和血栓栓塞,与多种基因作用有关。药物治疗是动脉狭窄患者治疗的基石,抗血栓治疗在其中起着至关重要的作用。无症状的颈动脉狭窄患者主要以药物治疗为主,症状性的患者需要通过颈动脉血管重建术干预,不建议为改善认知功能而对无症状的患者使用颈动脉血管重建术干预治疗,颈动脉血管重建术也对大多数患者有着明显受益,包括颈动脉支架置入术、颈动脉内膜剥脱术和经颈动脉血管重建术。颈动脉狭窄的患者的个体最适宜治疗方案的选择,仍是临床的关键问题。
Abstract: Carotid stenosis puts patients at risk of ischemic stroke, so the goal of clinical treatment is often to reduce the risk of stroke. Most patients with carotid stenosis are often asymptomatic in the clinic. The most common mechanism of stroke caused by carotid artery stenosis is plaque rupture and thromboembolism, which is related to many genes. Drug therapy is the cornerstone of the treatment of patients with arterial stenosis, and antithrombotic therapy plays a vital role in it. Asymptomatic patients with carotid artery stenosis are mainly treated with drugs. Symptomatic patients need to be intervened on by carotid artery revascularization. It is not recommended to use carotid artery revascularization for asymptomatic patients to improve cognitive function. Carotid artery revascularization also has obvious benefits for most patients, including carotid stent implantation, carotid endarterectomy and transcarotid artery revascularization. The choice of the most suitable treatment scheme for patients with carotid artery stenosis is still a key clinical problem.
文章引用:林阳, 赵文军. 颈动脉狭窄相关研究进展[J]. 临床医学进展, 2025, 15(5): 1744-1749. https://doi.org/10.12677/acm.2025.1551552

参考文献

[1] Howard, D.P.J., Gaziano, L. and Rothwell, P.M. (2021) Risk of Stroke in Relation to Degree of Asymptomatic Carotid Stenosis: A Population-Based Cohort Study, Systematic Review, and Meta-Analysis. The Lancet Neurology, 20, 193-202. [Google Scholar] [CrossRef] [PubMed]
[2] Stroke-Collaborators (2019) Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20, 795-820.
[3] Lovett, J.K., Coull, A.J. and Rothwell, P.M. (2004) Early Risk of Recurrence by Subtype of Ischemic Stroke in Population-Based Incidence Studies. Neurology, 62, 569-573. [Google Scholar] [CrossRef] [PubMed]
[4] Hofmann, A., Frank, F., Wolk, S., Busch, A., Klimova, A., Sabarstinski, P., et al. (2022) NOX4 mRNA Correlates with Plaque Stability in Patients with Carotid Artery Stenosis. Redox Biology, 57, Article ID: 102473. [Google Scholar] [CrossRef] [PubMed]
[5] Brandes, R.P., Weissmann, N. and Schröder, K. (2014) Nox Family NADPH Oxidases: Molecular Mechanisms of Activation. Free Radical Biology and Medicine, 76, 208-226. [Google Scholar] [CrossRef] [PubMed]
[6] Puertas-Umbert, L., Puig, N., Camacho, M., Dantas, A.P., Marín, R., Martí-Fàbregas, J., et al. (2022) Serum from Stroke Patients with High-Grade Carotid Stenosis Promotes Cyclooxygenase-Dependent Endothelial Dysfunction in Non-Ischemic Mice Carotid Arteries. Translational Stroke Research, 15, 140-152. [Google Scholar] [CrossRef] [PubMed]
[7] Cheng, S.F., Brown, M.M., Simister, R.J. and Richards, T. (2019) Contemporary Prevalence of Carotid Stenosis in Patients Presenting with Ischaemic Stroke. British Journal of Surgery, 106, 872-878. [Google Scholar] [CrossRef] [PubMed]
[8] Kleindorfer, D.O., Towfighi, A., Chaturvedi, S., Cockroft, K.M., Gutierrez, J., Lombardi-Hill, D., et al. (2021) 2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline from the American Heart Association/American Stroke Association. Stroke, 52, e364-e467. [Google Scholar] [CrossRef] [PubMed]
[9] Naylor, R., Rantner, B., Ancetti, S., de Borst, G.J., De Carlo, M., Halliday, A., et al. (2023) European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease. European Journal of Vascular and Endovascular Surgery, 65, 7-111.
[10] Heck, D. and Jost, A. (2021) Carotid Stenosis, Stroke, and Carotid Artery Revascularization. Progress in Cardiovascular Diseases, 65, 49-54. [Google Scholar] [CrossRef] [PubMed]
[11] Barnett, H.J.M., Taylor, D.W., et al. (1991) Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis. The New England Journal of Medicine, 325, 445-453. [Google Scholar] [CrossRef
[12] Walker, M.D. (1995) Endarterectomy for Asymptomatic Carotid Artery Stenosis. JAMA: The Journal of the American Medical Association, 273, 1421-1428. [Google Scholar] [CrossRef
[13] Halliday, A., Mansfield, A., Marro, J., et al. (2004) Prevention of Disabling and Fatal Strokes by Successful Carotid Endarterectomy in Patients without Recent Neurological Symptoms: Randomised Controlled Trial. Lancet, 363, 1491-1502.
[14] Donners, S.J.A., Mekke, J.M., van Hattum, E.S., Toorop, R.J. and de Borst, G.J. (2022) Editor’s Choice—Risk of Bleeding Complications with Different Peri-Operative Antithrombotic Regimens during Carotid Endarterectomy: A National Registry Analysis. European Journal of Vascular and Endovascular Surgery, 64, 444-451. [Google Scholar] [CrossRef] [PubMed]
[15] Bonati, L.H., Dobson, J., Featherstone, R.L., Ederle, J., van der Worp, H.B., de Borst, G.J., et al. (2015) Long-Term Outcomes after Stenting versus Endarterectomy for Treatment of Symptomatic Carotid Stenosis: The International Carotid Stenting Study (ICSS) Randomised Trial. The Lancet, 385, 529-538. [Google Scholar] [CrossRef] [PubMed]
[16] de Borst, G.J. and Naylor, A.R. (2015) In the End, It All Comes down to the Beginning! European Journal of Vascular and Endovascular Surgery, 50, 271-272. [Google Scholar] [CrossRef] [PubMed]
[17] Macdonald, S., Lee, R., Williams, R. and Stansby, G. (2009) Towards Safer Carotid Artery Stenting: A Scoring System for Anatomic Suitability. Stroke, 40, 1698-1703. [Google Scholar] [CrossRef] [PubMed]
[18] de Waard, D.D., de Vries, E.E., Huibers, A.E., Arnold, M.M., Nederkoorn, P.J., van Dijk, L.C., et al. (2019) A Clinical Validation Study of Anatomical Risk Scoring for Procedural Stroke in Patients Treated by Carotid Artery Stenting in the International Carotid Stenting Study. European Journal of Vascular and Endovascular Surgery, 58, 664-670. [Google Scholar] [CrossRef] [PubMed]
[19] Stonko, D.P., Goldsborough, E., Kibrik, P., Zhang, G., Holscher, C.M. and Hicks, C.W. (2022) Use of Transcarotid Artery Revascularization, Transfemoral Carotid Artery Stenting, and Carotid Endarterectomy in the US from 2015 to 2019. JAMA Network Open, 5, e2231944. [Google Scholar] [CrossRef] [PubMed]
[20] Müller, M.D., Lyrer, P., Brown, M.M. and Bonati, L.H. (2020) Carotid Artery Stenting versus Endarterectomy for Treatment of Carotid Artery Stenosis. Cochrane Database of Systematic Reviews, 2, CD000515. [Google Scholar] [CrossRef] [PubMed]
[21] Pucite, E., Krievina, I., Miglane, E., Erts, R., Krievins, D. and Millers, A. (2019) Changes in Cognition, Depression and Quality of Life after Carotid Stenosis Treatment. Current Neurovascular Research, 16, 47-62. [Google Scholar] [CrossRef] [PubMed]
[22] Plessers, M., Van Herzeele, I., Hemelsoet, D., Vermassen, F. and Vingerhoets, G. (2015) Prospective Comparison of Cognitive Effects of Carotid Endarterectomy versus Carotid Stenting with Flow Reversal or Distal Filters. Journal of Clinical and Experimental Neuropsychology, 37, 834-841. [Google Scholar] [CrossRef] [PubMed]
[23] Rockman, C., Caso, V. and Schneider, P.A. (2022) Carotid Interventions for Women: The Hazards and Benefits. Stroke, 53, 611-623. [Google Scholar] [CrossRef] [PubMed]